Aligos Therapeutics, Inc.

NASDAQ:ALGS

39.34 (USD) • At close December 24, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q22018 Q1
Omzet 1.2691.0610.9862.6813.2396.8862.7233.5374.1063.6932.5710.3671.5371.5450.9102.02600000000
Kosten van de omzet 00.610.6740.7750.6810.7690.8440.8970.9060.8890.98328.59828.13224.55422.86928.08117.33217.17617.302000000
Brutowinst 1.2690.4510.3121.9062.5586.1171.8792.643.22.8041.588-28.231-26.595-23.009-21.959-28.081-15.306-17.176-17.302000000
Brutowinstmarge 10.4250.3160.7110.790.8880.690.7460.7790.7590.618-76.924-17.303-14.893-24.1310-7.55500000000
Onderzoek- en ontwikkelingskosten 16.77421.09916.36622.25715.86716.78118.13519.117.79116.5131.67628.59828.13224.55422.86928.08117.33217.17617.30214.97311.7298.6688.6682.6142.614
Algemene en administratieve kosten 4.6266.3766.6666.4216.4439.2468.5067.1195.2637.5766.4529.7176.4736.5565.7816.2054.2254.0953.4193.4632.7751.8841.8840.8010.801
Verkoop- en marketingkosten 0-0.610-0.775000000000000000000000
Verkoop-, algemene en administratieve kosten 4.6265.7666.6665.6466.4439.2468.5067.1195.2637.5766.4529.7176.4736.5565.7816.2054.2254.0953.4193.4632.7751.8841.8840.8010.801
Overige kosten 031.345-13.373-0.460.0540.1520.2540-0.1820.304-0.09100.05-0.2980.0061.07-11.9740.0410.2240.0830.10800-6.831-6.831
Bedrijfskosten 21.426.86523.03227.90322.3126.02726.64126.21923.05424.08638.12838.31534.60531.1128.6534.28621.55721.27120.72118.43614.50410.49710.497-3.415-3.415
Bedrijfsresultaat -20.131-26.414-22.046-25.997-19.071-19.141-21.914-22.682-18.948-20.393-35.557-37.948-33.068-29.565-27.74-34.286-21.557-21.271-20.721-18.436-14.504-10.552-10.552-3.415-3.415
Bedrijfsresultaat ratio -15.864-24.895-22.359-9.697-5.888-2.78-8.048-6.413-4.615-5.522-13.83-103.401-21.515-19.136-30.4840-10.6400000000
Totaal overige inkomsten en kosten netto 0.96331.664-12.793-1.9251.0591.1071.0020.8450.2840.516-0.0050.1760.07-0.2250.1110.085-11.740.4150.6920.3370.4530.5370.537-0.068-0.068
Inkomen voor belasting -19.1685.25-34.839-27.922-18.012-18.034-22.916-21.837-18.664-19.877-35.562-37.772-32.998-29.79-27.629-34.201-33.297-20.856-20.029-18.099-14.051-10.015-10.015-3.483-3.483
Inkomen voor belasting ratio -15.1054.948-35.334-10.415-5.561-2.619-8.416-6.174-4.546-5.382-13.832-102.921-21.469-19.282-30.3620-16.43500000000
Belastingkosten 0.0910.189-0.024-0.030.0290.7570.0390.049-0.0430.0470.053-0.0580.1260.0280.0450.219-0.234-0.059-0.4680.085-0.34500-0.068-0.068
Nettowinst -19.2595.061-34.863-27.892-18.041-18.791-22.955-21.886-18.621-19.924-35.615-37.714-33.124-29.818-27.674-34.42-33.297-20.797-20.029-18.184-14.051-10.015-10.015-3.483-3.483
Nettowinstmarge -15.1774.77-35.358-10.404-5.57-2.729-8.43-6.188-4.535-5.395-13.853-102.763-21.551-19.3-30.4110-16.43500000000
WPA (Winst Per Aandeel) -3.070.81-5.58-1.12-0.41-0.43-0.53-0.51-0.44-0.47-0.84-0.89-0.78-0.79-0.74-1.09-0.9-0.95-0.91-0.83-0.64-0.46-0.46-0.16-0.16
Verwaterde WPA -3.070.81-5.58-1.12-0.41-0.43-0.53-0.51-0.44-0.47-0.84-0.89-0.78-0.79-0.74-1.09-0.9-0.95-0.91-0.83-0.64-0.46-0.46-0.16-0.16
EBITDA -19.464-26.414-21.372-27.147-18.39-18.372-23.074-22.16-17.758-19.504-34.579-37.948-32.031-28.865-26.756-33.318-20.842-20.312-20.261-17.792-13.878-10.311-10.311-3.161-3.161
EBITDA ratio -15.338-24.32-22.359-9.408-5.678-2.668-8.784-6.413-4.394-5.281-13.448-103.401-20.885-18.537-29.5240-10.20300000000